Midjourney pivots to healthcare with breakthrough 60-second full-body ultrasonic scanner

In an unexpected leap from software to medical hardware, generative artificial intelligence giant Midjourney has announced the launch of Midjourney Medical, a new healthcare division developing a full-body imaging system capable of scanning the human body in under 60 seconds. The announcement, delivered at a San Francisco corporate event by Midjourney founder David Holz, caught the tech and medical industries off guard.

Editorial credit: Robert Way / Shutterstock

The company is positioning its new "Midjourney Scanner" - a device utilizing a novel method it calls "Ultrasonic CT" - as a faster, radiation-free, and drastically lower-cost alternative to traditional magnetic resonance imaging (MRI) machines.

Echolocation in a pool of golden light

The technical framework of the Midjourney Scanner departs entirely from standard radiological procedures. Instead of utilizing the powerful magnetic fields of an MRI or the ionizing radiation of a CT scan, Midjourney's hardware relies on advanced acoustic imaging.

The physical system operates inside a specialized shallow water pool. A user steps onto a motorized platform that lowers them into the water at a steady rate of five centimeters per second. As the body descends, it passes through an underwater ring housing roughly half a million miniature ultrasonic sensors.

These sensors project ultra-precise sound waves through the body from every conceivable angle, capturing the resulting echoes, refractions, and structural interferences at an immense telemetry rate of 17 gigabytes of data per second.

A massive, dedicated 2-petaflop on-site compute ring then processes these raw sound waves, resolving the messy inverse-reconstruction data into a highly detailed, three-dimensional internal map of the user's muscles, fat, organs, and deep soft tissue down to a fraction of a millimeter. To establish its hardware footprint, Midjourney has partnered with semiconductor pioneer Butterfly Network in an eight-figure co-development deal worth up to $74 million over five years, leveraging Butterfly’s proprietary "Ultrasound-on-Chip" technology.

The wellness spa's alternative to the clinic

Rather than deploying these scanners directly into institutional hospital corridors, Midjourney is attempting to reframe preventive medical imaging as a consumer wellness ritual. The company unveiled plans to launch its flagship "Midjourney Spa" concept in San Francisco by late 2027.

The upscale commercial venues are designed to feature standard luxury amenities like hot tubs, saunas, and cold plunges, alongside dedicated private rooms housing the scanning pools. By removing the sterile, claustrophobic anxiety associated with traditional clinical environments, Holz intends to make regular, comprehensive internal checkups as routine as a dental cleaning. The venture's long-term roadmap is aggressively ambitious, aiming to establish a global fleet of 50,000 scanners capable of delivering 1 billion scans per month by 2031.

Skepticism and the regulatory gauntlet

Despite the immense enthusiasm within the technology sector, the announcement has drawn swift pushback from professional medical communities. Radiologists and clinical researchers have publicly cautioned against the company's aggressive marketing claims, pointing out the fundamental physics limitations inherent to ultrasound technology.

Medical experts note that high-frequency sound waves cannot easily penetrate dense bone or pockets of air within the body. Consequently, the Midjourney Scanner is structurally incapable of mapping neural tissue within the skull, meaning it cannot replace MRIs for brain imaging, and will struggle to accurately resolve deep structures encased in bone.

Medical analysts also warn that widespread, unregulated full-body screening will inevitably flood the healthcare system with thousands of anxious patients seeking complex diagnostic workups for completely benign cysts and harmless computational artifacts.

Recognizing these massive clinical hurdles, Midjourney is executing a conservative, staged regulatory strategy. The scanner will initially launch without any diagnostic medical capabilities attached. Instead, the company will market the device purely as a premium wellness tool that prints highly precise body-composition maps. Over the next twelve months, Midjourney plans to refine its reconstruction algorithms, conduct rigorous research trials at its initial facility, and systematically submit testing telemetry to the U.S. Food and Drug Administration (FDA) to slowly secure true diagnostic medical clearance.